The study, led by Olivier Zerbib and Shaul Lev of the Department of General Intensive Care at Hasharon Hospital, Rabin Medical Center in Petah Tikva, Israel, evaluated an electronic urinometer called the FIZE kUO in ten critically ill patients. The device is designed to measure urine output continuously and in real time, without any manual handling of the collection system. Instead of relying on periodic visual checks, the system transmits a live stream of urine output data, allowing clinicians to follow trends minute by minute rather than in snapshots separated by hours. The researchers describe it as an attempt to move urine monitoring from the same manual era that once characterized heart rate and blood pressure measurement, both of which have long since been automated at the bedside.

The rationale for automation goes beyond convenience. Manual urine output measurement is labor-intensive and interruptive, pulling nurses away from other time-sensitive tasks several times per hour in the sickest patients. Each measurement requires physical presence at the bedside, and delays are common when staffing is stretched. Missed or late recordings can create gaps in the fluid balance chart, and those gaps can obscure exactly the trend that matters most: a gradual decline in urine output that signals evolving kidney injury. In a unit where a single nurse may be responsible for one or two critically unstable patients, every interruption carries an opportunity cost, and every delayed data point carries a clinical one.

To capture how the device affected this dynamic, the team ran a prospective, single-center pilot study with a design centered on the people who actually use such technology: the nursing staff. Nurses completed staged questionnaires before, during, and after the monitoring period, comparing their perceptions of manual monitoring with their experience of the automated system. Device performance and any adverse events were documented throughout the entire monitoring period, giving the researchers both a usability picture and a safety record. The study was conducted under Good Clinical Practice guidelines, with ethical approval from the institutional review board of Rabin Medical Center and informed consent obtained from all patients or their legally authorized representatives.

The results paint a consistently favorable portrait of the technology from the nursing perspective. Staff reported high marks for ease of setup, with positive responses in the range of 84 to 87 percent, and roughly three quarters of nurses, 74 percent, said the system saved time. Perhaps most striking, 87 percent reported that continuous data improved their recognition of changes in urine output, the very capability that makes this measurement clinically valuable. By the end of the treatment period, 88.9 percent of nurses indicated that the system prevented missing data, and 78 percent said it facilitated earlier identification of situations requiring intervention. In the language of critical care, earlier recognition is often the difference between a corrective fluid adjustment and a full-blown episode of kidney failure.

Safety, the other essential pillar for any bedside device, also held up. Across the study the FIZE kUO provided continuous monitoring for a total of 1,263 patient-hours, an unusually long cumulative exposure for a pilot of this size, and the researchers observed no device-related adverse events and no serious adverse events. For a device that physically interfaces with the urinary collection system, a common source of infection risk in the ICU, that clean safety record is a meaningful early signal, though the authors and the study’s pilot design make clear that larger evaluations will be needed before broad conclusions can be drawn.

The study’s framing within the broader nursing workload literature is one of its more interesting dimensions. Intensive care nursing is measured in part by tools such as the Nursing Activities Score, which quantifies how much of a nurse’s time is consumed by direct and indirect care tasks. Manual measurement of urine output is precisely the kind of repetitive, low-judgment task that automation advocates argue should be shifted to machines, freeing human attention for the tasks that genuinely require clinical reasoning. The Israeli team’s findings support that argument from the user’s side: nurses perceived the device as reducing repetitive manual work and supporting timelier decision-making, a combination that speaks to both efficiency and quality of care.

There is also a technological lineage worth noting. Continuous monitoring has transformed other domains of critical care. Pulse oximetry replaced intermittent arterial blood gas sampling for oxygen saturation, capnography brought continuous carbon dioxide tracking to ventilated patients, and arterial lines deliver beat-to-beat blood pressure data. Urine output, by contrast, has remained stubbornly analog, recorded in hourly or every-few-hours increments that depend on someone physically walking to the bedside. A continuous electronic urinometer effectively brings urine output into the same data ecosystem as the other vital signs, where it can be displayed on central monitors, trended by clinical information systems, and potentially paired with automated alerts when output falls below thresholds associated with acute kidney injury.

The clinical stakes of that transition are considerable. Acute kidney injury affects a substantial fraction of ICU patients and is strongly associated with mortality, yet it is frequently recognized late because its earliest signs are subtle and its most accessible marker, urine output, is recorded intermittently and sometimes incompletely. Guidelines for kidney injury staging explicitly incorporate urine output criteria over time windows, which means the accuracy and granularity of urine data directly influence diagnosis. Continuous measurement could, in principle, allow clinicians to detect the gradual oliguria that defines early kidney injury hours sooner than a chart reviewed every four hours. The pilot study did not test patient outcomes directly, but the perception among nurses that the system enabled earlier identification of situations requiring intervention points toward exactly that potential benefit.

As with any early-stage evaluation, the caveats are real. The study enrolled ten patients at a single center, was sponsored by FIZE Medical Ltd., the device’s manufacturer, though the authors declare no personal financial relationships or employment with the company, and its endpoints were perceptions, workflow, and safety rather than hard clinical outcomes. Questionnaire-based usability studies capture experience, not efficacy, and the leap from nurses liking a device to patients doing better requires larger, outcome-focused trials. Still, the pattern of results across more than a thousand hours of monitoring, the absence of safety signals, and the strong majorities on every usability measure give the technology a credible foundation. If subsequent studies confirm these findings at scale, the humble urine bottle at the ICU bedside may follow the same path as the mercury sphygmomanometer: a faithful manual tool that eventually gave way to something faster, cleaner, and continuously watching. For the nurses who spend their shifts racing between monitors, ventilators, and medication pumps, that would mean one less interruption and one more reason to trust the numbers on the screen.

Subject of Research: Automated continuous urine output monitoring in intensive care using an electronic urinometer

Article Title: From manual to digital: prospective ICU evaluation of the FIZE kUO® for continuous urine output measurement

Article References: Zerbib, O., Mahamid, T., Ben-Noon, N., & Lev, S. (2026). From manual to digital: prospective ICU evaluation of the FIZE kUO® for continuous urine output measurement. BMC Nursing. https://doi.org/10.1186/s12912-026-05421-1

Image Credits: AI Generated

DOI: 10.1186/s12912-026-05421-1

Keywords: urine output, ICU, nursing workload, acute kidney injury, electronic urinometer, FIZE kUO, critical care monitoring, fluid management, medical device, automation, pilot study, BMC Nursing

The metric, introduced by a team of researchers at the Children’s Hospital of Chongqing Medical University led by Dong Li, Xiaowei Xiong, Chunxiao Wang, Changyang Ye, Ke Bai, and Chengjun Liu, is called the Fluid Overload Ultrafiltration Percentage, or FOUP. The concept is mathematically straightforward: instead of expressing fluid removal in absolute terms or normalized to body weight, FOUP expresses the cumulative net fluid balance as a percentage of the child’s initial fluid overload—the excess fluid the patient carried at the start of therapy. In doing so, it reframes the question from how much fluid was removed to how much of the existing burden was eliminated. A child who begins treatment 10 percent fluid overloaded and loses 5 percent of that excess has, by this logic, achieved something qualitatively different from a child with minimal overload who loses the same absolute volume.

The rationale for this reframing comes from a growing body of evidence linking fluid overload to poor outcomes in pediatric critical care. Prior research, including systematic reviews and meta-analyses cited by the authors, has associated positive fluid balance with increased mortality in critically ill children, and studies of continuous renal replacement therapy have shown that the degree of fluid overload at initiation influences survival. Yet the conventional metrics used to titrate therapy do not account for the starting point. The net ultrafiltration rate is weight-dependent and says nothing about whether the removal is proportionate to the overload. The net fluid balance is an absolute number that similarly requires the clinician to mentally reference the baseline burden before it becomes interpretable. FOUP, the authors hypothesized, could make that contextualization automatic and reveal patterns that the older metrics obscure.

To test the hypothesis, the researchers analyzed 220 children who received continuous renal replacement therapy for at least 72 hours. For each patient, they calculated FOUP, net ultrafiltration rate, and net fluid balance across three consecutive 24-hour intervals, allowing them to track not just static values but trajectories over the crucial first three days of therapy. They then stratified the surviving patients into subgroups based on the severity of initial fluid overload, using a cutoff of 5 percent, and based on the capillary leak index, a composite marker of vascular permeability with a cutoff of 3.3, as well as by body weight. The capillary leak index matters because children with leaky capillaries distribute fluid differently, moving it from the bloodstream into tissues, which complicates both the assessment of overload and the hemodynamic tolerance of its removal.

The comparison between survivors and non-survivors produced a striking asymmetry. Among the 84 children who died, baseline fluid overload was substantially higher—6.6 percent compared with 2.4 percent in survivors, a difference that reached statistical significance. The non-survivors also received higher net ultrafiltration rates at every time point measured. Yet when the researchers looked at the net fluid balance and the FOUP achieved, the two groups were similar. In other words, the children who died were subjected to more aggressive removal per kilogram of body weight but did not end up with proportionally greater reduction of their fluid burden, a discrepancy that the conventional metrics alone could not have exposed. The trajectories of the ultrafiltration rate also diverged in a telling way: survivors showed a declining rate over the study period, while non-survivors showed a rising one, and both trends were statistically significant.

The most clinically provocative finding emerged from the subgroup analysis of survivors who were at high risk—those with initial fluid overload of 5 percent or greater, or a capillary leak index of 3.3 or higher. In these patients, FOUP traced a distinctly biphasic pattern. In the first 24 hours, fluid removal was vigorous, with FOUP reaching approximately minus 43.3 percent, meaning nearly half of the initial fluid excess was cleared within a single day. But over the subsequent 48 to 72 hours, the curve flattened dramatically, with FOUP changing by only 2.0 to 4.1 percent, a plateau that was highly significant statistically. Crucially, this plateau occurred despite the continued delivery of high ultrafiltration rates. The machine kept pulling fluid, but the proportional reduction of the overload stalled—a signal, the authors argue, of diminishing returns.

Why would continued high-intensity ultrafiltration stop translating into proportional fluid burden reduction? The study’s data offer a clue in the hemodynamic figures. Throughout the first 72 hours of therapy, the high-risk survivors maintained hemodynamic stability, which the authors documented in their analysis of cardiovascular parameters. This suggests that the plateau was not simply a consequence of clinicians backing off to prevent blood pressure crashes. Rather, it points toward the physiology of fluid distribution: in patients with significant capillary leak, fluid removed from the intravascular space may be continuously replenished from the interstitial compartment, so that the net proportional clearance of the total overload lags far behind the raw ultrafiltration volume. FOUP, by normalizing to the initial burden, makes this decoupling visible in a way that a stable ultrafiltration rate does not.

The practical implication the authors draw from these patterns is a shift toward response-adaptive fluid management. Under a FOUP-guided framework, which the team sketches as an iterative cycle in their published figures, the intensity of ultrafiltration would be titrated not against a fixed weight-based target but against the measured response of the fluid burden itself. When FOUP shows rapid proportional clearance, as it did in the first 24 hours of high-risk patients, aggressive removal appears productive. When FOUP plateaus, as it did at 48 to 72 hours, the data suggest that pushing the ultrafiltration rate higher yields little additional proportional benefit while potentially increasing the risk of hemodynamic instability. The metric thus offers a physiological rationale for easing off, rather than an arbitrary protocol threshold.

The study carries the usual caveats of retrospective observational research. It was conducted at a single institution, the Children’s Hospital affiliated with Chongqing Medical University, with ethics approval and a waiver of individual informed consent given the retrospective design, and the analysis reflects the practice patterns of one center. The biphasic pattern describes an association observed in survivors of high-risk subgroups; it does not by itself prove that tapering ultrafiltration after the plateau improves outcomes. That question would require prospective testing, ideally in a randomized framework comparing FOUP-guided management with conventional rate- or balance-based protocols. The authors’ funding came from a Chongqing regional medical research project, and they report no competing interests.

Even so, the conceptual contribution is likely to resonate beyond pediatrics. Fluid management on continuous kidney replacement therapy remains one of the most contested territories in intensive care, with trials in adults exploring protocolized versus monitoring-driven approaches and observational studies documenting wide practice variation. FOUP joins a family of normalized indices—such as percent fluid overload itself and the capillary leak index—that attempt to convert raw volumes into physiologically meaningful proportions. Its distinctive move is to normalize the removal, not just the burden, creating a ratio that is interpretable without reference to body weight or baseline volume status. If prospective studies confirm that the biphasic trajectory holds across centers and that response-adaptive titration improves survival or reduces complications, a simple percentage could reshape how intensivists think about one of their most delicate daily decisions: not how much fluid to take out, but how much of the burden remains to be taken.

Subject of Research: A novel fluid removal metric (FOUP) for pediatric continuous renal replacement therapy

Article Title: The Fluid Overload Ultrafiltration Percentage (FOUP): a novel metric that contextualizes fluid removal to initial burden in pediatric CRRT

Article References: The Fluid Overload Ultrafiltration Percentage (FOUP): a novel metric that contextualizes fluid removal to initial burden in pediatric CRRT. (n.d.). https://doi.org/10.1038/s41390-026-05469-4

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05469-4

Keywords: FOUP, pediatric CRRT, fluid overload, ultrafiltration, net fluid balance, capillary leak index, critical care, acute kidney injury, fluid management, hemodynamics, Pediatric Research, intensive care

Bronchopulmonary dysplasia, or BPD, is a chronic lung disease defined clinically by the continued need for respiratory support or supplemental oxygen at 36 weeks of postmenstrual age. It affects a substantial fraction of very preterm survivors and carries lifelong consequences, including increased risks of asthma-like symptoms, rehospitalization, impaired growth, and neurodevelopmental difficulties. The disorder arises from an intricate interplay of prematurity itself, inflammation, mechanical ventilation, oxygen toxicity, infection, and disturbed fluid homeostasis. Because the preterm lung must transition from a fluid-filled fetal state to an air-filled neonatal one within minutes to days, the way water moves into and out of the body during that transition has long been suspected to matter. Excess extracellular water can flood the pulmonary interstitium, worsen compliance, prolong the need for ventilation, and thereby amplify lung injury. This biological logic underpins the standard practice of restricting fluid intake and watching for a postnatal weight loss of roughly five to fifteen percent in the first week as a sign that the infant is clearing fluid appropriately.

The new study set out to characterize the longitudinal trajectories of fluid output, fluid balance, and related indicators across the first seven days of life, and then to test how those trajectories relate to moderate-to-severe BPD, classified according to the 2018 NICHD criteria. The investigators assembled a single-center retrospective cohort of very preterm infants who survived to 36 weeks postmenstrual age, and they applied generalized linear mixed models, a statistical framework well suited to repeated daily measurements nested within individual patients. This approach allowed them to compare day-by-day curves of fluid intake, output, balance, intake-to-output ratio, and weight loss between infants who later developed severe lung disease and those who did not, while adjusting for confounding factors. Their primary exposure was the cumulative fluid output over postnatal days three through seven, a window chosen because the earliest days are dominated by physiological transitions and measurement noise, whereas days three to seven better reflect sustained fluid handling.

Among the 211 infants included, 77, or 36.5 percent, developed moderate-to-severe BPD, a rate consistent with the substantial burden of disease in this gestational age range. When the daily trajectories were compared, one signal stood out: fluid balance over the first week behaved differently in the two groups, with a statistically significant BPD-by-time interaction for daily balance. Daily output, intake, intake-to-output ratio, and percentage weight loss did not differ significantly day by day between the groups. Yet when the researchers turned to cumulative measures across days three to seven, the pattern became sharper and, in one respect, inverted expectations. Every 10 milliliter per kilogram increase in cumulative fluid output over that five-day span was independently associated with higher odds of moderate-to-severe BPD, with an adjusted odds ratio of 1.073 and a 95 percent confidence interval of 1.031 to 1.115.

The crucial methodological move in the study was to separate output from intake. In observational neonatal data, output and intake are tightly coupled, because clinicians often adjust prescribed fluids in response to what the infant is losing, and because balance is by definition the arithmetic difference between the two. A naive analysis of net balance alone can therefore conflate the effects of giving too much fluid with the effects of losing fluid. The authors addressed this by constructing a joint model containing both cumulative output and cumulative intake over days three to seven. In that model, output retained a robust independent association with BPD, while cumulative intake was not statistically significant, with an adjusted odds ratio of 0.961 and a confidence interval of 0.924 to 0.999 that just crossed the null. A reference model using cumulative balance alone showed a reciprocal protective-sounding trend, with an adjusted odds ratio of 0.942, meaning a more positive balance appeared associated with lower odds of severe disease, a finding that is the mirror image of the output result and underscores how strongly the choice of exposure metric shapes conclusions.

That inversion is what makes the study provocative. Conventional neonatal teaching emphasizes cumulative net balance as the key target: a positive balance, meaning more fluid retained than excreted, is traditionally viewed as a risk factor for BPD because it implies pulmonary edema. The new data instead suggest that infants who went on to develop severe lung disease were, if anything, those with higher fluid losses in the first week, even after accounting for how much fluid they received. Several biological interpretations are possible, and the authors are careful to frame their findings as hypothesis generating rather than practice changing. High output could be a marker rather than a cause: infants who are sicker from the start, exposed to more inflammation or receiving nephrotoxic or diuretic medications, may both lose more fluid and be more likely to develop BPD for reasons unrelated to water handling. Alternatively, excessive fluid losses could reflect immature renal concentrating ability, and the resulting dehydration, electrolyte disturbance, and reduced circulating volume might impair perfusion and recovery of the developing lung.

There is also a plausible measurement story. Insensible water losses through the skin and respiratory tract of extremely preterm infants are enormous and difficult to quantify precisely, particularly under radiant warmers or phototherapy, and recorded output in retrospective chart data may miss stool losses or capture errors in weighing diapers. The daily trajectories analysis supports this caution: daily balance, a composite that integrates unmeasured losses implicitly, did show a significant group-by-time difference, while directly recorded daily output did not. Cumulative indices over days three to seven may smooth random error and reveal signal that single-day comparisons miss, but they also amplify any systematic bias in how fluids are charted. The single-center design, while ensuring consistent local practice, limits generalizability to centers with different fluid protocols, humidification strategies, or ventilation practices, and the retrospective nature means confounding by indication can never be fully excluded, even with statistical adjustment.

Statistically, the adjusted odds ratio of roughly 1.07 per 10 milliliters per kilogram is modest in magnitude but clinically meaningful when applied to the large fluid volumes handled over five days: a cumulative output difference of 100 milliliters per kilogram would translate into nearly a doubling of the odds in this model. Still, the confidence interval for intake came tantalizingly close to significance, and the reciprocal balance result suggests that the underlying associations are entangled in ways that only prospective, protocolized data collection can resolve. The study was retrospectively registered in the Chinese Clinical Trial Registry on 10 January 2025, and it was approved by the Institutional Review Board of Shanghai Children’s Medical Center with the consent requirement waived for the use of de-identified retrospective data. The authors declare no competing interests, and the work received no external funding.

For clinicians, the immediate takeaway is not to abandon careful fluid restriction but to pay closer attention to the output side of the ledger. Tracking cumulative output during days three to seven may offer an early window into which infants are at heightened risk of severe BPD, potentially prompting intensified respiratory care, closer renal monitoring, or earlier engagement of families in discussions about long-term follow-up. For researchers, the study identifies a clear agenda: prospective cohorts that simultaneously measure insensible losses, renal biomarkers, biompedance-based estimates of extracellular water, and echocardiographic markers such as hemodynamically significant patent ductus arteriosus, to determine whether high output is a cause, a consequence, or a correlated signature of lung vulnerability. Until such studies arrive, the authors’ message is measured but pointed. The neonatal fluid conversation has been dominated by how much fluid goes in; these findings insist that how much comes out deserves equal scientific scrutiny, and that the humble daily fluid chart, long treated as bookkeeping, may contain underexploited clues to one of prematurity’s most stubborn complications.

Subject of Research: Association of first-week fluid output trajectories with moderate-to-severe bronchopulmonary dysplasia in very preterm infants

Article Title: Association between fluid trajectories in the first postnatal week and moderate-to-severe bronchopulmonary dysplasia in very preterm infants: a retrospective cohort study

Article References: Wang, S., Chen, X., Bei, F., & Bu, J. (2026). Association between fluid trajectories in the first postnatal week and moderate-to-severe bronchopulmonary dysplasia in very preterm infants: a retrospective cohort study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07728-z

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07728-z

Keywords: bronchopulmonary dysplasia, fluid output, fluid balance, very preterm infant, neonatology, retrospective cohort study, fluid management, prematurity, chronic lung disease, postnatal fluid trajectories, Association, between

Sodium dominates the chemistry of the body’s extracellular fluid, accounting for roughly ninety percent of its osmolality. The plasma sodium concentration therefore serves as a sensitive barometer of the balance between sodium and water intake and excretion. Hypernatremia, defined as a plasma sodium concentration exceeding 145 millimoles per liter, arises whenever there is a net gain of sodium, a deficit of free water, or a combination of both, and it is invariably accompanied by hyperosmolality. The review also highlights a subtlety that laboratory reports obscure: because only about ninety-three percent of plasma volume is actually water, the physiologically active sodium concentration is slightly higher than the measured value. In hyperglycemic patients, osmotic water shifts from inside cells to the extracellular space can dilute the measured sodium and mask the true severity of the disturbance.

Under normal circumstances, the body defends its osmolality with remarkable precision. Osmoreceptors in the hypothalamus detect even small rises in plasma osmolality and trigger two compensatory responses: the release of antidiuretic hormone from the posterior pituitary, which increases water reabsorption in the collecting tubules of the kidney, and the activation of thirst. Antidiuretic hormone secretion begins when plasma osmolality exceeds approximately 275 to 285 milliosmoles per kilogram, while thirst is triggered at a slightly higher threshold. Hypovolemia independently stimulates hormone release, and expanded blood volume mildly suppresses it. Crucially, even when the kidney achieves maximal urinary concentration, it cannot offset insensible water losses without additional intake, making an intact thirst response indispensable. Intensive care dismantles this defense: sedation, intubation, and impaired consciousness silence thirst, creating a dysregulated regulatory loop in which patients cannot signal their own dehydration.

The scale of the problem is substantial. ICU-acquired hypernatremia affects between six and forty-seven percent of patients depending on the definition, timing of diagnosis, and clinical setting, and multiple cohorts have linked it independently with increased mortality. The elderly are particularly vulnerable because aging raises the osmotic threshold for thirst and reduces baroreceptor sensitivity. The causes divide into two broad categories: free water deficits caused by reduced intake or excessive losses, and positive sodium balance caused by sodium administration or impaired sodium excretion. Non-renal water losses include vomiting, diarrhea, insensible losses, and drainage from surgical sites, while renal losses can follow osmotic diuresis driven by non-reabsorbed solutes such as glucose, mannitol, or urea, or impaired urinary concentrating ability in diabetes insipidus, tubular dysfunction, or recovering acute kidney injury.

Among the underappreciated culprits, the authors single out urea-mediated osmotic diuresis. Increased urea generation associated with burn injury, sepsis, polytrauma, high-protein feeding, or recovery from acute kidney injury elevates urine osmolality and can quietly increase electrolyte-free water losses. Exogenous glucocorticoids, widely used in septic shock, may compound the problem by enhancing urea-mediated osmotic diuresis and possibly suppressing antidiuretic hormone secretion. On the sodium side of the ledger, inappropriate renal retention can result from mineralocorticoid excess, including glucocorticoid therapy, while in shock states the expected suppression of the renin-angiotensin-aldosterone system may be blunted by hemodynamic instability and sympathoadrenergic activation, perpetuating sodium retention. Notably, studies in polytrauma patients have observed reduced urinary sodium and chloride excretion before hypernatremia developed, suggesting that impaired natriuresis is not merely a consequence but may be an early warning sign.

Iatrogenic sodium loading deserves equal scrutiny. Every sodium-containing intravenous fluid contributes to the daily sodium load regardless of its tonicity, and therapeutic hypertonic saline can raise serum sodium rapidly. Less obvious contributors include certain antibiotics such as fosfomycin, trisodium-citrate anticoagulation during continuous renal replacement therapy, sodium bicarbonate, enteral and parenteral nutrition, and drug-dilution fluids prepared in 0.9 percent saline, which contains 154 millimoles of sodium per liter. Even potassium administration, particularly during correction of major potassium deficits, can raise serum sodium by causing intracellular water shifts. These insights reframe hypernatremia prevention as a matter of auditing the total daily sodium burden rather than simply reacting to a laboratory number.

The physiological consequences extend well beyond the laboratory values. Hypernatremia impairs insulin-mediated glucose uptake and glucagon-dependent glucose release, contributing to hyperglycemia. In the central nervous system, osmotic fluid shifts can shrink brain cells and damage cerebral vessels, potentially producing neurological deficits or delirium. Experimental data further suggest that hyperosmolality may impair myocardial contractility through the induction of proinflammatory cytokines, hinting that elevated osmolality could compound the cardiovascular dysfunction already present in critically ill patients. These systemic effects help explain the consistent association between hypernatremia and death across observational cohorts, though the authors are careful to note that association does not prove causation.

Diagnostically, the review prescribes a structured approach anchored in assessment of volume status and urine production. Calculation of the free water deficit and free water clearance helps determine the appropriate volume and rate of fluid replacement, with the free water deficit computed from total body water and the difference between the current sodium concentration and a target of 140 millimoles per liter. In critically ill patients, the authors argue that electrolyte-free water clearance, which incorporates urinary sodium and potassium concentrations, may more accurately reflect ongoing water losses than conventional free water clearance, particularly when urea- or glucose-driven osmotic diuresis is suspected. This distinction matters because a patient losing electrolyte-free water through an osmotic diuresis needs a very different fluid strategy than one retaining sodium.

Treatment, the review emphasizes, must target the underlying cause rather than applying a one-size-fits-all water infusion. In hypovolemic patients, resuscitation with isotonic fluids takes priority, with free water added only once hemodynamic stability is achieved. In euvolemic or hypervolemic patients with adequate urine output, the focus shifts to quantifying and reducing the daily sodium load. Replacing 0.9 percent saline drug solvents with glucose-based solutions, adopting low-sodium maintenance fluid strategies, and limiting fluid creep have all been shown to lower the incidence of hypernatremia, although drug compatibility and stability constraints must be considered when changing diluents. Perhaps most provocatively, the long-standing teaching that serum sodium should be corrected at a rate below 0.5 millimoles per liter per hour has been challenged by a large analysis suggesting that faster correction may be safe and associated with shorter hospitalization and decreased mortality, a finding likely to spark debate among nephrologists and intensivists.

Pharmacological options remain limited but evolving. Hydrochlorothiazide was tested as an adjunct for ICU-acquired hypernatremia in a single small randomized controlled trial that showed no significant effect. A separate trial of forty fluid-overloaded ICU patients found that adding indapamide to furosemide produced larger natriuresis, 210 versus 119 millimoles of sodium, with similar urine volumes, and the furosemide-only group, unlike the combination group, experienced a rise in serum sodium after twenty-four hours. Mineralocorticoid receptor antagonists can induce natriuresis and represent a potential therapy, though clinical data are lacking. Animal work has shown that free water improves sodium mobilization in furosemide-treated pigs after a hyperosmotic sodium load, supporting combined strategies, while renal replacement therapy remains an option when free water administration risks fluid overload. For diabetes insipidus, management depends on etiology: nephrogenic cases call for correcting electrolyte disturbances and reversible causes, whereas central diabetes insipidus typically responds to desmopressin. The authors conclude that hypernatremia in the critically ill demands a thorough evaluation of fluid status, electrolytes, and urine chemistry, grounded in a clear understanding of the underlying physiology, if outcomes are to improve.

Subject of Research: ICU-acquired hypernatremia and its mechanisms, diagnosis, and management in critically ill patients

Article Title: Hypernatremia in the critically Ill: beyond free water replacement

Article References: Paraskevas, T., Ostermann, M., & Joannidis, M. (2026). Hypernatremia in the critically Ill: beyond free water replacement. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08566-4

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08566-4

Keywords: hypernatremia, ICU-acquired hypernatremia, sodium regulation, antidiuretic hormone, osmoreceptors, free water deficit, osmotic diuresis, electrolyte-free water clearance, fluid management, critical care, diabetes insipidus, intensive care medicine